212 related articles for article (PubMed ID: 27940167)
21. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
[TBL] [Abstract][Full Text] [Related]
22. Polysaccharide-induced order-to-order transitions in lyotropic liquid crystals.
Mezzenga R; Grigorov M; Zhang Z; Servais C; Sagalowicz L; Romoscanu AI; Khanna V; Meyer C
Langmuir; 2005 Jul; 21(14):6165-9. PubMed ID: 15982017
[TBL] [Abstract][Full Text] [Related]
23. The influence of mannose-based esters on the mesophase behaviour of lyotropic liquid crystalline nanosystems as drug delivery vectors.
Tiboni M; Astolfi P; Verboni M; Benedetti S; Giorgini E; Notarstefano V; Vita F; Ranieri S; Duranti A; Lucarini S; Casettari L; Pisani M
Colloids Surf B Biointerfaces; 2023 Dec; 232():113596. PubMed ID: 37918304
[TBL] [Abstract][Full Text] [Related]
24. Temperature triggering of kinetically trapped self-assemblies in citrem-phospholipid nanoparticles.
Prajapati R; Salentinig S; Yaghmur A
Chem Phys Lipids; 2018 Nov; 216():30-38. PubMed ID: 30222973
[TBL] [Abstract][Full Text] [Related]
25. Microstructure evaluation of dermally applicable liquid crystals as a function of water content and temperature: Can electron paramagnetic resonance provide complementary data?
Matjaž MG; Mravljak J; Rogač MB; Šentjurc M; Gašperlin M; Pobirk AZ
Int J Pharm; 2017 Nov; 533(2):431-444. PubMed ID: 28528851
[TBL] [Abstract][Full Text] [Related]
26. The influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersions.
Shen HH; Crowston JG; Huber F; Saubern S; McLean KM; Hartley PG
Biomaterials; 2010 Dec; 31(36):9473-81. PubMed ID: 20880581
[TBL] [Abstract][Full Text] [Related]
27. Size-Dependent Encapsulation and Release of dsDNA from Cationic Lyotropic Liquid Crystalline Cubic Phases.
Sarkar S; Tran N; Soni SK; Conn CE; Drummond CJ
ACS Biomater Sci Eng; 2020 Aug; 6(8):4401-4413. PubMed ID: 33455184
[TBL] [Abstract][Full Text] [Related]
28. Predicting the complex phase behavior of self-assembling drug delivery nanoparticles.
Le TC; Mulet X; Burden FR; Winkler DA
Mol Pharm; 2013 Apr; 10(4):1368-77. PubMed ID: 23464802
[TBL] [Abstract][Full Text] [Related]
29. Bioadhesive lipid compositions: self-assembly structures, functionality, and medical applications.
Barauskas J; Christerson L; Wadsäter M; Lindström F; Lindqvist AK; Tiberg F
Mol Pharm; 2014 Mar; 11(3):895-903. PubMed ID: 24422996
[TBL] [Abstract][Full Text] [Related]
30. Oleoylethanolamide-based lyotropic liquid crystals as vehicles for delivery of amino acids in aqueous environment.
Mohammady SZ; Pouzot M; Mezzenga R
Biophys J; 2009 Feb; 96(4):1537-46. PubMed ID: 19217870
[TBL] [Abstract][Full Text] [Related]
31. Novel RAFT amphiphilic brush copolymer steric stabilisers for cubosomes: poly(octadecyl acrylate)-block-poly(polyethylene glycol methyl ether acrylate).
Chong JY; Mulet X; Postma A; Keddie DJ; Waddington LJ; Boyd BJ; Drummond CJ
Soft Matter; 2014 Sep; 10(35):6666-76. PubMed ID: 25058647
[TBL] [Abstract][Full Text] [Related]
32. Phytantriol based smart nano-carriers for drug delivery applications.
Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
[TBL] [Abstract][Full Text] [Related]
33. Structural Investigation of Bulk and Dispersed Inverse Lyotropic Hexagonal Liquid Crystalline Phases of Eicosapentaenoic Acid Monoglyceride.
Yaghmur A; Al-Hosayni S; Amenitsch H; Salentinig S
Langmuir; 2017 Dec; 33(49):14045-14057. PubMed ID: 29136473
[TBL] [Abstract][Full Text] [Related]
34. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
Zhai J; Fong C; Tran N; Drummond CJ
ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
[TBL] [Abstract][Full Text] [Related]
35. Novel steric stabilizers for lyotropic liquid crystalline nanoparticles: PEGylated-phytanyl copolymers.
Chong JY; Mulet X; Keddie DJ; Waddington L; Mudie ST; Boyd BJ; Drummond CJ
Langmuir; 2015 Mar; 31(9):2615-29. PubMed ID: 25068381
[TBL] [Abstract][Full Text] [Related]
36. Adsorption of lipid liquid crystalline nanoparticles: effects of particle composition, internal structure, and phase behavior.
Chang DP; Jankunec M; Barauskas J; Tiberg F; Nylander T
Langmuir; 2012 Jul; 28(29):10688-96. PubMed ID: 22725977
[TBL] [Abstract][Full Text] [Related]
37. Cell medium-dependent dynamic modulation of size and structural transformations of binary phospholipid/ω-3 fatty acid liquid crystalline nano-self-assemblies: Implications in interpretation of cell uptake studies.
Bor G; Salentinig S; Şahin E; Nur Ödevci B; Roursgaard M; Liccardo L; Hamerlik P; Moghimi SM; Yaghmur A
J Colloid Interface Sci; 2022 Jan; 606(Pt 1):464-479. PubMed ID: 34399363
[TBL] [Abstract][Full Text] [Related]
38. New lipid family that forms inverted cubic phases in equilibrium with excess water: molecular structure-aqueous phase structure relationship for lipids with 5,9,13,17-tetramethyloctadecyl and 5,9,13,17-tetramethyloctadecanoyl chains.
Yamashita J; Shiono M; Hato M
J Phys Chem B; 2008 Oct; 112(39):12286-96. PubMed ID: 18774852
[TBL] [Abstract][Full Text] [Related]
39. Solvation Dynamics in Different Phases of the Lyotropic Liquid Crystalline System.
Roy B; Satpathi S; Gavvala K; Koninti RK; Hazra P
J Phys Chem B; 2015 Sep; 119(35):11721-31. PubMed ID: 26258397
[TBL] [Abstract][Full Text] [Related]
40. Phase behavior of lipid-based lyotropic liquid crystals in presence of colloidal nanoparticles.
Venugopal E; Bhat SK; Vallooran JJ; Mezzenga R
Langmuir; 2011 Aug; 27(16):9792-800. PubMed ID: 21749073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
